Illumina Innovation — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Serimmuneserimmune.comNov 2023SEC filingmedium confidence

BiotechGoleta, US

Patrick Daugherty(Executive Officer, Director)Kristin Loomis(Director)Bill Welch(Director)inNick Naclerio(Director)inJohn Shon(Executive Officer)

Board seatNicholas Naclerio· per SEC Form D · $16.5M raise · filed Nov 2023

Co-investorsIllumina Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.